SCHEMBL22499595

SCHEMBL22499595

CN(C)S(=O)(=O)c1cc(C(=O)O)ccc1N1CCN(CCCCC(F)(F)F)CC1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ERAP1 Q9NZ08 7/20 0.45
HRH1 P35367 2/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MCOLN3 Q8TDD5 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
DRD2 P14416 2/20 0.36
DRD4 P21917 2/20 0.36
DRD3 P35462 1/20 0.36
MAPT P10636 1/20 0.36
TTR P02766 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29384773 1.00 ERAP1 (0.45) ERAP1HRH1ALDH1A1CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL11714575 0.81 ALDH1A1 (0.45) ERAP1ALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL11710337 0.80 ERAP1 (0.54) ERAP1ALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL29399998 0.80 DRD2 (0.41) ALDH1A1DRD2DRD4DRD3MAPT
Hydrochloric Acid SCHEMBL11717209 0.79 ERAP1 (0.53) ERAP1ALDH1A1CYP1A2CYP3A4CYP2D6
Bromide SCHEMBL11706601 0.77 ALDH1A1 (0.53) ALDH1A1CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL11718138 0.77 ALDH1A1 (0.45) ERAP1ALDH1A1CYP1A2CYP3A4CYP2D6
Phenylpiperazine SCHEMBL11768963 0.72 GPR55 (0.46) ERAP1ALDH1A1DRD3MAPT
SCHEMBL22515474 0.72 HDAC3 (0.41) ALDH1A1SMN1; SMN2MAPT
SCHEMBL22499537 0.72 HDAC3 (0.41) ALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3947345-A1 MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION Fondazione Istituto Italiano di Tecnologia (IT) 2022-02-09 EP claimed
WO-2020202072-A1 MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) 2020-10-08 WO claimed
US-20220184008-A1 MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) 2022-06-16 US disclosed
CN-114174259-A Modulators of intracellular chloride concentration 意大利学院科技基金会 2022-03-11 CN disclosed
EP-3947345-A1 MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION Fondazione Istituto Italiano di Tecnologia (IT) 2022-02-09 EP disclosed
WO-2020202072-A1 MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) 2020-10-08 WO disclosed
WO-2020202072-A1 MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) 2020-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220184008-A1 MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION SLC6A1, SLC6A13, SLC6A11 ERAP1 2279/4885HRH1 4532/4885ALDH1A1 2711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.